Answer
Degarelix acetate competitively and reversibly blocks pituitary GnRH receptors, rapidly reducing release of luteinizing hormone (LH) and follicle stimulating hormone (FSH), thereby reducing testosterone secretion by the testes.
Sources for this answer
- Firmagon 80mg InjectionFerring Pharmaceuticals Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 15Document updated
Sources checked